The APAC medical robots market is expected to grow from US$ 1,893.25 million in 2022 to US$ 5,351.40 million by 2028; it is estimated to grow at a CAGR of 18.9% from 2022 to 2028.
Nanorobots play an important role in bio-medicine, majorly for treating cancer and cerebral aneurysms, removing kidney stones, and eliminating defective parts in the DNA structure. The current stages of medical technologies and therapy tools are used to treat cancer successfully. For successful treatment, efficient drug delivery is important to decrease the side effects of chemotherapy. Nanorobots with implanted chemical biosensors are used to detect the tumor cells in the early stages of cancer development inside a patient’s body. Nanosensors are utilized to find the intensity of E-cadherin signals. In many cancer cases, drugs can cause side effects because they cannot differentiate between cancer cells and healthy ones. The nanorobots target only tumors and do not cause clotting elsewhere in the body. Therefore, side effects can be avoided in cancer treatment. Manufacturers and scientists have been investing in innovative technological developments. For instance, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences, Arizona State University scientists have programmed nanorobots to shrink tumors by cutting off their blood supply. They have developed the first fully autonomous DNA robotic system for precise drug design and targeted cancer therapy. So, the evolution of nanorobots for cancer treatment is expected to drive the market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC medical robots market . The APAC medical robots market is expected to grow at a good CAGR during the forecast period.
Nanorobots play an important role in bio-medicine, majorly for treating cancer and cerebral aneurysms, removing kidney stones, and eliminating defective parts in the DNA structure. The current stages of medical technologies and therapy tools are used to treat cancer successfully. For successful treatment, efficient drug delivery is important to decrease the side effects of chemotherapy. Nanorobots with implanted chemical biosensors are used to detect the tumor cells in the early stages of cancer development inside a patient’s body. Nanosensors are utilized to find the intensity of E-cadherin signals. In many cancer cases, drugs can cause side effects because they cannot differentiate between cancer cells and healthy ones. The nanorobots target only tumors and do not cause clotting elsewhere in the body. Therefore, side effects can be avoided in cancer treatment. Manufacturers and scientists have been investing in innovative technological developments. For instance, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences, Arizona State University scientists have programmed nanorobots to shrink tumors by cutting off their blood supply. They have developed the first fully autonomous DNA robotic system for precise drug design and targeted cancer therapy. So, the evolution of nanorobots for cancer treatment is expected to drive the market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC medical robots market . The APAC medical robots market is expected to grow at a good CAGR during the forecast period.
APAC Medical Robots Market Segmentation
The APAC medical robots market is segmented based on product, end user, application, and country.- Based on product, the APAC medical robots market is segmented into surgical robots, hospital & pharmacy robots, rehabilitation robots, non-invasive radiosurgery robots, and others. The surgical robots segment dominated the market in 2022.
- Based on application, the APAC medical robots market is segmented into laparoscopy, neurology, orthopedics, gynecology, urology, cardiology, and others. The laparoscopy segment dominated the market in 2022.
- Based on end user, the APAC medical robots market is segmented into hospitals, ambulatory surgical centers and others. The hospitals segment dominated the market in 2022.
- Based on country, the APAC medical robots market has been segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China would dominate the market in 2022.
Table of Contents
1. Introduction
3. Research Methodology
4. APAC Medical Robots Market - Market Landscape
5. APAC Medical Robots Market - Key Market Dynamics
6. Medical Robots Market- APAC Analysis
7. APAC Medical Robots Market Analysis - By Product
8. APAC Medical Robots Market Analysis - By Application
9. APAC Medical Robots Market Analysis - By End User
10. APAC Medical Robots Market Analysis - By Country
11. Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accuray Incorporated
- ARxIUM
- Auris Medical
- Ekso Bionics
- Hocoma AG
- Intuitive Surgicals
- Kirby Lester
- Medtronic
- Omnicell Inc.
- Stryker Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 192 |
| Published | September 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1893.25 Million |
| Forecasted Market Value ( USD | $ 5351.4 Million |
| Compound Annual Growth Rate | 18.9% |
| Regions Covered | Asia Pacific |
